Opposing views or like-minded? International Working Group and Alzheimer’s Association criteria
Year: 2025
Type: article
Abstract: The 2024 AA and IWG diagnostic criteria for Alzheimer’s disease differ in their classification of asymptomatic individuals. Verberk et al. argue, however, that their shared requirement for biomarker use in diagnosis means they are now largely aligned, marking a pivotal step towards precision medicine in dementia care.
Source: Brain
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,570
Funders: Eli Lilly and Company, Philips, Biogen, Danone, Health~Holland, Noaber Foundation, Roche Nederland, Amsterdam University Medical Centers, ZonMw, Fujifilm Corporation, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Eisai, Stichting Dioraphte, Alzheimer Nederland, Amsterdam Neuroscience, European Brain Council, GIESKES-STRIJBIS FONDS
OpenAlex ID: W4414715732
